David Buchsbaum

ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation.

Founded in 1932, Stanford Group Co. is a broker/dealer headquartered in Houston, Texas with offices nationwide. They are a subsidiary of Stanford Financial Services, Inc. and their ultimate parent is CBaySystems Holdings Ltd. The firm offers a full range of brokerage services for both domestic and international clients. They are a member of the NASD and the SIPC. Stanford's research includes both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. Their equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, healthcare, technology and water/environment sectors, targeting small- and mid-cap companies. Their policy analysts deliver investment relevant insights across a broad range of sectors, including geopolitics, international/trade, Federal Reserve board policy, health care (including services, medical devices and pharmaceuticals, telecom, media, financial services, water/environment, agribusiness/tobacco, energy) and technology (including information technology services, homeland security and biometrics/emerging technologies).

Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO.